METTL1 and neoplasm: Recent studies have shown that METTL1 is closely associated with processes involved in the progression of diseases, including tumour proliferation, migration, invasion, angiogenesis, chemo‐ and radiotherapy resistance, energy metabolism and TIME suppression.